JP2004500055A - Ｐｅｃｔｉｎｏｐｈｏｒａｇｏｓｓｙｐｉｅｌｌａ（ピンクワタノミムシ）Ｂａｃｉｌｌｕｓｔｈｕｒｉｎｇｉｅｎｓｉｓ（バシラススリンギエンシス）毒素受容体ＢＴ−Ｒ２ - Google Patents
Ｐｅｃｔｉｎｏｐｈｏｒａｇｏｓｓｙｐｉｅｌｌａ（ピンクワタノミムシ）Ｂａｃｉｌｌｕｓｔｈｕｒｉｎｇｉｅｎｓｉｓ（バシラススリンギエンシス）毒素受容体ＢＴ−Ｒ２ Download PDFInfo
- Publication number
- JP2004500055A JP2004500055A JP2001537503A JP2001537503A JP2004500055A JP 2004500055 A JP2004500055 A JP 2004500055A JP 2001537503 A JP2001537503 A JP 2001537503A JP 2001537503 A JP2001537503 A JP 2001537503A JP 2004500055 A JP2004500055 A JP 2004500055A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- toxin
- seq
- nucleic acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108700012359 toxins Proteins 0.000 title claims abstract description 156
- 239000003053 toxin Substances 0.000 title claims abstract description 155
- 231100000765 toxin Toxicity 0.000 title claims abstract description 152
- 241000193388 Bacillus thuringiensis Species 0.000 title claims abstract description 67
- 229940097012 bacillus thuringiensis Drugs 0.000 title claims abstract description 67
- 241000721451 Pectinophora gossypiella Species 0.000 title claims abstract description 13
- 241000254173 Coleoptera Species 0.000 title description 10
- 229920000742 Cotton Polymers 0.000 claims abstract description 28
- 230000003013 cytotoxicity Effects 0.000 claims abstract description 6
- 231100000135 cytotoxicity Toxicity 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 101
- 102000004169 proteins and genes Human genes 0.000 claims description 97
- 102000005962 receptors Human genes 0.000 claims description 77
- 108020003175 receptors Proteins 0.000 claims description 77
- 150000001413 amino acids Chemical class 0.000 claims description 24
- 150000007523 nucleic acids Chemical class 0.000 claims description 20
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 18
- 108020004707 nucleic acids Proteins 0.000 claims description 17
- 102000039446 nucleic acids Human genes 0.000 claims description 17
- 241000255789 Bombyx mori Species 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 108010061334 Cry toxin receptors Proteins 0.000 claims description 10
- 239000000523 sample Substances 0.000 claims description 10
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 230000009471 action Effects 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 241000239290 Araneae Species 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- 241000208125 Nicotiana Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000027455 binding Effects 0.000 abstract description 68
- 241000238631 Hexapoda Species 0.000 abstract description 31
- 239000012634 fragment Substances 0.000 abstract description 24
- 239000002299 complementary DNA Substances 0.000 abstract description 23
- 230000024033 toxin binding Effects 0.000 abstract description 20
- 238000000034 method Methods 0.000 abstract description 16
- 238000004458 analytical method Methods 0.000 abstract description 10
- 238000010367 cloning Methods 0.000 abstract description 10
- 238000012512 characterization method Methods 0.000 abstract description 9
- 239000002917 insecticide Substances 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 4
- 238000003556 assay Methods 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 3
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 89
- 210000004027 cell Anatomy 0.000 description 56
- 239000012528 membrane Substances 0.000 description 30
- 210000004379 membrane Anatomy 0.000 description 29
- 241000724266 Broad bean mottle virus Species 0.000 description 26
- 241000219146 Gossypium Species 0.000 description 24
- 102000023732 binding proteins Human genes 0.000 description 20
- 108091008324 binding proteins Proteins 0.000 description 20
- 239000000872 buffer Substances 0.000 description 18
- 102000000905 Cadherin Human genes 0.000 description 16
- 108050007957 Cadherin Proteins 0.000 description 16
- 241000255908 Manduca sexta Species 0.000 description 13
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 230000000749 insecticidal effect Effects 0.000 description 12
- 239000003446 ligand Substances 0.000 description 12
- 239000013615 primer Substances 0.000 description 12
- 210000000110 microvilli Anatomy 0.000 description 10
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 10
- 231100000419 toxicity Toxicity 0.000 description 10
- 230000001988 toxicity Effects 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 241000607479 Yersinia pestis Species 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 230000001086 cytosolic effect Effects 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000000159 protein binding assay Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000255777 Lepidoptera Species 0.000 description 5
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 210000004962 mammalian cell Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011534 wash buffer Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 238000001378 electrochemiluminescence detection Methods 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000010820 immunofluorescence microscopy Methods 0.000 description 4
- 238000001114 immunoprecipitation Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002287 radioligand Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 4
- QZDDFQLIQRYMBV-UHFFFAOYSA-N 2-[3-nitro-2-(2-nitrophenyl)-4-oxochromen-8-yl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(C=2[N+]([O-])=O)=O)=C1OC=2C1=CC=CC=C1[N+]([O-])=O QZDDFQLIQRYMBV-UHFFFAOYSA-N 0.000 description 3
- 102100022749 Aminopeptidase N Human genes 0.000 description 3
- 108090000915 Aminopeptidases Proteins 0.000 description 3
- 102000004400 Aminopeptidases Human genes 0.000 description 3
- 241000197194 Bulla Species 0.000 description 3
- 108010049990 CD13 Antigens Proteins 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 241000256259 Noctuidae Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108091005461 Nucleic proteins Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000002352 blister Diseases 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 3
- 108010052968 leupeptin Proteins 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenyl methane sulfonyl fluoride Natural products FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 108010087765 Antipain Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101710151559 Crystal protein Proteins 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 240000002024 Gossypium herbaceum Species 0.000 description 2
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 2
- 241000256244 Heliothis virescens Species 0.000 description 2
- 241000721703 Lymantria dispar Species 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 241000287127 Passeridae Species 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 102000003923 Protein Kinase C Human genes 0.000 description 2
- 108090000315 Protein Kinase C Proteins 0.000 description 2
- 108700040559 Protocadherins Proteins 0.000 description 2
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000006957 competitive inhibition Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000012202 endocytosis Effects 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229950000964 pepstatin Drugs 0.000 description 2
- 108010091212 pepstatin Proteins 0.000 description 2
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000730 protein immunoprecipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000449794 Alabama argillacea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000011103 Cadherin Related Proteins Human genes 0.000 description 1
- 108010023070 Cadherin Related Proteins Proteins 0.000 description 1
- 101100448444 Caenorhabditis elegans gsp-3 gene Proteins 0.000 description 1
- 101100448445 Caenorhabditis elegans gsp-4 gene Proteins 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 1
- 101000984015 Homo sapiens Cadherin-1 Proteins 0.000 description 1
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 1
- 101000735376 Homo sapiens Protocadherin-8 Proteins 0.000 description 1
- 101000735368 Homo sapiens Protocadherin-9 Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108050000637 N-cadherin Proteins 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000721452 Pectinophora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 240000001857 Phyllostachys elegans Species 0.000 description 1
- 241000595626 Plodia Species 0.000 description 1
- 241001611556 Pluchea odorata Species 0.000 description 1
- 241000500439 Plutella Species 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000015537 Protein Kinase C-alpha Human genes 0.000 description 1
- 108010050276 Protein Kinase C-alpha Proteins 0.000 description 1
- 102100034958 Protocadherin-8 Human genes 0.000 description 1
- 102100034957 Protocadherin-9 Human genes 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 230000010799 Receptor Interactions Effects 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 241000256250 Spodoptera littoralis Species 0.000 description 1
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000255993 Trichoplusia ni Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- -1 aprotonin Chemical compound 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000069 breast epithelial cell Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000002777 columnar cell Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 108091065295 delta endotoxin family Proteins 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000008497 endothelial barrier function Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 102000047933 human CDH1 Human genes 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000010807 negative regulation of binding Effects 0.000 description 1
- 230000004766 neurogenesis Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 201000002740 oral squamous cell carcinoma Diseases 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 210000000064 prostate epithelial cell Anatomy 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000019617 pupation Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000018866 regulation of programmed cell death Effects 0.000 description 1
- 230000012865 response to insecticide Effects 0.000 description 1
- 230000032537 response to toxin Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16156499P | 1999-10-26 | 1999-10-26 | |
| PCT/US2000/041521 WO2001034807A2 (en) | 1999-10-26 | 2000-10-25 | Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2? |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500055A true JP2004500055A (ja) | 2004-01-08 |
| JP2004500055A5 JP2004500055A5 (enExample) | 2005-01-06 |
Family
ID=22581713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001537503A Pending JP2004500055A (ja) | 1999-10-26 | 2000-10-25 | Ｐｅｃｔｉｎｏｐｈｏｒａｇｏｓｓｙｐｉｅｌｌａ（ピンクワタノミムシ）Ｂａｃｉｌｌｕｓｔｈｕｒｉｎｇｉｅｎｓｉｓ（バシラススリンギエンシス）毒素受容体ＢＴ−Ｒ２ |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6660497B1 (enExample) |
| EP (1) | EP1224287A2 (enExample) |
| JP (1) | JP2004500055A (enExample) |
| AU (1) | AU784994B2 (enExample) |
| CA (1) | CA2388829A1 (enExample) |
| HK (1) | HK1050212A1 (enExample) |
| WO (1) | WO2001034807A2 (enExample) |
| ZA (1) | ZA200203273B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060491B1 (en) * | 1999-11-18 | 2006-06-13 | Pioneer Hi-Bred International, Inc. | Polynucleotides encoding novel BT toxin receptors from lepidopteran insects |
| CA2391384C (en) * | 1999-11-18 | 2007-05-01 | Pioneer Hi-Bred International, Inc. | Bt toxin receptors from lepidopteran insects and methods of use |
| WO2001064844A1 (en) | 2000-03-01 | 2001-09-07 | Clemson University | Intermittent immersion vessel apparatus and process for plant propagation |
| AU2002305051A1 (en) * | 2001-03-15 | 2002-10-03 | Clemson University | Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins |
| MXPA05009790A (es) | 2003-03-14 | 2005-11-17 | Pioneer Hi Bred Int | Receptores novedosos de la toxina bt y metodos de uso. |
| EP1715745A2 (en) | 2004-01-22 | 2006-11-02 | The University Of Georgia Research Foundation, Inc. | Peptides for inhibiting insects |
| EP3415010A1 (en) | 2017-06-13 | 2018-12-19 | Agrosavfe Nv | Insect-controlling polypeptides and methods |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998059048A1 (en) * | 1997-06-20 | 1998-12-30 | University Of Wyoming | Receptor for a bacillus thuringiensis toxin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5693491A (en) | 1994-10-19 | 1997-12-02 | University Of Wyoming | Receptor for a Bacillus thuringiensis toxin |
-
2000
- 2000-10-24 US US09/696,115 patent/US6660497B1/en not_active Expired - Fee Related
- 2000-10-25 CA CA002388829A patent/CA2388829A1/en not_active Abandoned
- 2000-10-25 WO PCT/US2000/041521 patent/WO2001034807A2/en not_active Ceased
- 2000-10-25 EP EP00989693A patent/EP1224287A2/en not_active Withdrawn
- 2000-10-25 AU AU26173/01A patent/AU784994B2/en not_active Ceased
- 2000-10-25 HK HK03100669.7A patent/HK1050212A1/zh unknown
- 2000-10-25 JP JP2001537503A patent/JP2004500055A/ja active Pending
-
2002
- 2002-04-24 ZA ZA200203273A patent/ZA200203273B/xx unknown
-
2003
- 2003-07-18 US US10/623,366 patent/US7094554B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998059048A1 (en) * | 1997-06-20 | 1998-12-30 | University Of Wyoming | Receptor for a bacillus thuringiensis toxin |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001034807A3 (en) | 2001-11-01 |
| US20040040059A1 (en) | 2004-02-26 |
| EP1224287A2 (en) | 2002-07-24 |
| AU784994B2 (en) | 2006-08-17 |
| CA2388829A1 (en) | 2001-05-17 |
| AU2617301A (en) | 2001-06-06 |
| US6660497B1 (en) | 2003-12-09 |
| ZA200203273B (en) | 2003-11-11 |
| WO2001034807A2 (en) | 2001-05-17 |
| US7094554B2 (en) | 2006-08-22 |
| HK1050212A1 (zh) | 2003-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Flannagan et al. | Identification, cloning and expression of a Cry1Ab cadherin receptor from European corn borer, Ostrinia nubilalis (Hübner)(Lepidoptera: Crambidae) | |
| Darboux et al. | The receptor of Bacillus sphaericus binary toxin in Culex pipiens (Diptera: Culicidae) midgut: molecular cloning and expression | |
| Herrero et al. | Bacillus thuringiensis Cry1Ca-resistant Spodoptera exigua lacks expression of one of four Aminopeptidase N genes | |
| Zhang et al. | Mutation of an aminopeptidase N gene is associated with Helicoverpa armigera resistance to Bacillus thuringiensis Cry1Ac toxin | |
| Hua et al. | Anopheles gambiae cadherin AgCad1 binds the Cry4Ba toxin of Bacillus thuringiensis israelensis and a fragment of AgCad1 synergizes toxicity | |
| Pigott et al. | Role of receptors in Bacillus thuringiensis crystal toxin activity | |
| Bravo et al. | Oligomerization triggers binding of a Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N receptor leading to insertion into membrane microdomains | |
| Chen et al. | Aedes aegypti cadherin serves as a putative receptor of the Cry11Aa toxin from Bacillus thuringiensis subsp. israelensis | |
| Xue et al. | Cloning and characterization of a novel Cry1A toxin from Bacillus thuringiensis with high toxicity to the Asian corn borer and other lepidopteran insects | |
| Flores-Escobar et al. | Differential role of Manduca sexta aminopeptidase-N and alkaline phosphatase in the mode of action of Cry1Aa, Cry1Ab, and Cry1Ac toxins from Bacillus thuringiensis | |
| Fabrick et al. | Binding of Bacillus thuringiensis toxin Cry1Ac to multiple sites of cadherin in pink bollworm | |
| Hua et al. | Fluorescent-based assays establish Manduca sexta Bt-R1a cadherin as a receptor for multiple Bacillus thuringiensis Cry1A toxins in Drosophila S2 cells | |
| Romão et al. | A second independent resistance mechanism to Bacillus sphaericus binary toxin targets its α‐glucosidase receptor in Culex quinquefasciatus | |
| Ferreira et al. | Bacterial larvicides for vector control: mode of action of toxins and implications for resistance | |
| Aroonkesorn et al. | Two specific membrane-bound aminopeptidase N isoforms from Aedes aegypti larvae serve as functional receptors for the Bacillus thuringiensis Cry4Ba toxin implicating counterpart specificity | |
| Chen et al. | Functional characterization of Aedes aegypti alkaline phosphatase ALP1 involved in the toxicity of Cry toxins from Bacillus thuringiensis subsp. israelensis and jegathesan | |
| Opota et al. | Identification and characterization of the receptor for the Bacillus sphaericus binary toxin in the malaria vector mosquito, Anopheles gambiae | |
| Hua et al. | AgCad2 cadherin in Anopheles gambiae larvae is a putative receptor of Cry11Ba toxin of Bacillus thuringiensis subsp. jegathesan | |
| Park et al. | Dual function of a bee (Apis cerana) inhibitor cysteine knot peptide that acts as an antifungal peptide and insecticidal venom toxin | |
| JP2004500055A (ja) | Ｐｅｃｔｉｎｏｐｈｏｒａｇｏｓｓｙｐｉｅｌｌａ（ピンクワタノミムシ）Ｂａｃｉｌｌｕｓｔｈｕｒｉｎｇｉｅｎｓｉｓ（バシラススリンギエンシス）毒素受容体ＢＴ−Ｒ２ | |
| Liu et al. | The defined toxin-binding region of the cadherin G-protein coupled receptor, BT-R1, for the active Cry1Ab toxin of Bacillus thuringiensis | |
| Wang et al. | Identification of two Bacillus thuringiensis Cry3Aa toxin-binding aminopeptidase N from Rhynchophorus ferrugineus (Coleoptera: Curculionidae) | |
| Hu et al. | Generation of Human Domain Antibody Fragments as Potential Insecticidal Agents against Helicoverpa armigera by Cadherin-Based Screening | |
| Jneid et al. | Bacillus thuringiensis Cry1A toxins divert progenitor cells toward enteroendocrine fate by decreasing cell adhesion with intestinal stem cells | |
| CA3175030A1 (en) | Novel insecticidal toxin receptors and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071025 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100811 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101111 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101118 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110405 |